Akèy › Kansè tiwoyid › Massachusetts
Etid klinik pou Kansè tiwoyid nan Massachusetts
7 etid pou Kansè tiwoyid ap chèche patisipan nan sit nan Massachusetts.
Vil nan Massachusetts
Tèks ofisyèl etid la (Anglè)
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Dana-Farber Cancer Institute, Boston
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05786924XL092 and Cemiplimab in BRAF WT Thyroid Cancer
- Dana Farber/Harvard Cancer Center, Boston
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06902376Integrated Cancer Repository for Cancer Research
- Holyoke Medical Center, Holyoke
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699Hereditary Risk Factors for Thyroid Cancer
- Dana Farber Cancer Institute, Boston
Ap rekriteVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Jun 11, 2026 · NCT02747888A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Massachusetts General Hospital,, Boston
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Massachusetts General Hospital, Boston
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT06239194Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
- Massachusetts General Hospital, Boston
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Dec 12, 2024 · NCT05668962Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.